Promotional price valid on web orders only. Your contract pricing may differ. Interested in signing up for a dedicated account number?
Learn More
Learn More
Human EphB4 Antibody, R&D Systems™

Goat Polyclonal Antibody has been used in 7 publications
Supplier: R&D Systems AF3038
This item is not returnable.
View return policy
Description
EphB4 Polyclonal specifically detects EphB4 in Human samples. It is validated for Western Blot, Simple Western, Flow Cytometry, Immunohistochemistry, CyTOF-ready, Knockout Validated.Specifications
EphB4 | |
Polyclonal | |
Unconjugated | |
P54760 | |
EPHB4 | |
Mouse myeloma cell line NS0-derived recombinant human EphB4 Leu16-Ala539 Accession # P54760 | |
100 μg | |
Primary | |
Detects human EphB4 in direct ELISAs and Western blots. In direct ELISAs, less than 10% cross-reactivity with recombinant mouse (rm) EphB4 is observed and less than 1% cross-reactivity with recombinant human (rh) EphA4, rhEphA3, rhEphB2, and rhEphB3 is observed. | |
Human | |
IgG |
Western Blot, Flow Cytometry, Immunohistochemistry, CyTOF | |
LYOPH | |
Western Blot 2 ug/mL, Simple Western 50 ug/mL, Flow Cytometry 0.25 ug/10^6 cells, Immunohistochemistry 5-15 ug/mL, CyTOF-ready | |
EC 2.7.10, EC 2.7.10.1, EPH receptor B4, EphB4, ephrin type-B receptor 4, hepatoma transmembrane kinase, Htk, HTKephrin receptor EphB4, Mdk2, Myk1, soluble EPHB4 variant 1, soluble EPHB4 variant 2, soluble EPHB4 variant 3, Tyro11, Tyrosine-protein kinase receptor HTK, Tyrosine-protein kinase TYRO11 | |
Goat | |
Affinity Purified | |
RUO | |
2050 | |
Reconstitute at 0.2 mg/mL in sterile PBS. | |
Use a manual defrost freezer and avoid repeated freeze-thaw cycles. 12 months from date of receipt, -20 to -70 degreesC as supplied. 1 month, 2 to 8 degreesC under sterile conditions after reconstitution. 6 months, -20 to -70 degreesC under sterile conditions after reconstitution. |
Product Content Correction
Your input is important to us. Please complete this form to provide feedback related to the content on this product.
Product Title
Spot an opportunity for improvement?Share a Content Correction